PTEN Mutations in Bladder Cancer
Author Information
Author(s): Aveyard J S, Skilleter A, Habuchi T, Knowles M A
Primary Institution: ICRF Cancer Medicine Research Unit, St James's University Hospital
Hypothesis
Is the PTEN gene involved in the development of bladder carcinoma?
Conclusion
The study found that PTEN is involved in the development of some bladder tumors, but mutations are infrequent.
Supporting Evidence
- The study screened 123 bladder tumors for loss of heterozygosity in the PTEN region.
- In muscle invasive tumors, allele loss was detected in 24.5% of cases.
- LOH was found in 6.6% of non-invasive tumors.
- Two homozygous deletions of PTEN were identified in muscle invasive tumors.
Takeaway
Researchers looked at bladder tumors to see if a gene called PTEN was causing cancer, and they found it was involved but not often mutated.
Methodology
The study screened bladder tumors for loss of heterozygosity and PTEN mutations using various genetic analysis techniques.
Limitations
The study may not account for other mechanisms of PTEN inactivation.
Participant Demographics
Included muscle invasive and non-invasive bladder tumors.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website